Idarucizumab may reverse dabigatran anticoagulation in intracranial hemorrhage

LOS ANGELES – It only took a few minutes for idarucizumab to normalize blood-clotting parameters in 18 patients with dabigatran-associated intracranial hemorrhages, according to interim results from...

Source: Clinical Neurology News - March 23, 2016 Category: Neurology Source Type: news